Samuel Murray

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Renal Cell Carcinoma

Mesenchymal Stem Cells

Top Venues

JCO precision oncology

Molecular cancer research : MCR

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ritesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, Andrea Knezevic, Samuel Murray, Ian Johnson, Natalie Shapnik, Darren R Feldman, Maria Isabel Carlo, Neil J Shah, Marisa Dunigan, Kety Huberman, Ryma Benayed, Ahmet Zehir, Michael F Berger, Marc Ladanyi, Dana Wai Yi Tsui, Robert J Motzer, Chung-Han Lee, Martin H Voss
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. JCO precision oncology 6 (2022)
Jack Patrick Gleeson, Ines Nikolovski, Renzo Dinatale, Mark Zucker, Andrea Knezevic, Sujata Patil, Yasser Ged, Ritesh R Kotecha, Natalie Shapnik, Samuel Murray, Paul Russo, Jonathan Coleman, Chung Han Lee, Zsofia K Stadler, A Ari Hakimi, Darren R Feldman, Robert J Motzer, Ed Reznik, Martin H Voss, Ying-Bei Chen, Maria Isabel Carlo
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Chung-Han Lee, Renzo G DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero, Lynda Vuong, Mark Lee, Kate Weiss, Doug Hoen, Luc Morris, Ed Reznik, Samuel Murray, Ritesh R Kotecha, Martin H Voss, Maria Isabel Carlo, Darren R Feldman, Pallavi Sachdev, Yusuke Adachi, Yukinori Minoshima, Junji Matsui, Yasuhiro Funahashi, Kenichi Nomoto, A Ari Hakimi, Robert J Motzer, Timothy A Chan
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab. Molecular cancer research : MCR 19 (9) (2021)